94-126. Physicians' Laboratory Service, Inc. (Former Licensee) Bozeman, MT; Order Imposing Civil Monetary Penalty  

  • [Federal Register Volume 59, Number 3 (Wednesday, January 5, 1994)]
    [Notices]
    [Pages 608-610]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-126]
    
    
    [[Page Unknown]]
    
    [Federal Register: January 5, 1994]
    
    
    -----------------------------------------------------------------------
    
    NUCLEAR REGULATORY COMMISSION
    [Docket No. 030-20111, License No. 25-21258-01, EA 93-202]
    
     
    
    Physicians' Laboratory Service, Inc. (Former Licensee) Bozeman, 
    MT; Order Imposing Civil Monetary Penalty
    
    I
    
        Physicians' Laboratory Service, Inc. (Licensee or PLS) was the 
    holder of NRC License No. 25-21258-01 (License) issued by the Nuclear 
    Regulatory Commission (NRC or Commission). The License, which was 
    transferred to Bozeman Deaconess Hospital on July 2, 1993, authorized 
    the Licensee to possess and use byproduct material to conduct nuclear 
    medicine activities in accordance with the conditions of the License.
    
    II
    
        An inspection of the Licensee's activities was conducted July 14-
    16, 1993. The results of this inspection indicated that the Licensee 
    had not conducted its activities in full compliance with NRC 
    requirements. A written Notice of Violation and Proposed Imposition of 
    Civil Penalty (Notice) was served upon the Licensee by letter dated 
    October 18, 1993. The Notice described the circumstances surrounding 
    the violations, the provisions of the NRC's requirements that the 
    Licensee had violated, and the amount of the civil penalty proposed for 
    the violations.
        The Licensee responded to the Notice in a letter dated November 17, 
    1993. In its letter, the Licensee admitted the violations which 
    resulted in the proposed civil penalty, but requested that the NRC 
    reconsider the circumstances surrounding the violations and mitigate 
    the proposed civil penalty for reasons that are summarized in the 
    Appendix to this order.
    
    III
    
        After consideration of the Licensee's response and the statements 
    of fact, explanation, and argument for mitigation contained therein, 
    the NRC staff has determined, as set forth in the Appendix to this 
    Order, that the violations occurred as stated and that the penalty 
    proposed for the violations designated in the Notice should be imposed.
    
    IV
    
        In view of the foregoing and pursuant to section 234 of the Atomic 
    Energy Act of 1954, as amended (Act), 42 U.S.C. 2282, and 10 CFR 2.205, 
    It is hereby ordered That:
    
        The Licensee pay the civil penalty in the amount of $2,500 
    within 30 days of the date of this Order, by check, draft, money 
    order, or electronic transfer, payable to the Treasurer of the 
    United States and mailed to the Director, Office of Enforcement, 
    U.S. Nuclear Regulatory Commission, ATTN: Document Control Desk, 
    Washington, DC 20555.
    
    V
    
        The Licensee may request a hearing within 30 days of the date of 
    this Order. A request for a hearing should be clearly marked as a 
    ``Request for an Enforcement Hearing,'' and shall be addressed to the 
    Director, Office of Enforcement, U.S. Nuclear Regulatory Commission, 
    ATTN: Document Control Desk, Washington, DC 20555. Copies also shall be 
    sent to the Assistant General Counsel for Hearings and Enforcement at 
    the same address and to the Regional Administrator, NRC Region IV, 611 
    Ryan Plaza Drive, Suite 400, Arlington, Texas 76011.
        If a hearing is requested, the Commission will issue an Order 
    designating the time and place of the hearing. If the Licensee fails to 
    request a hearing within 30 days of the date of this Order, the 
    provisions of this Order shall be effective without further 
    proceedings. If payment has not been made by that time, the matter may 
    be referred to the Attorney General for collection.
        In the event the Licensee requests a hearing as provided above, the 
    issue to be considered at such hearing shall be:
    
        Whether, on the basis of the violations admitted by the 
    Licensee, this Order should be sustained.
    
        Dated at Rockville, Maryland this 22nd day of December 1993.
    
        For the Nuclear Regulatory Commission.
    Hugh L. Thompson, Jr.,
    Deputy Executive Director for Nuclear Materials Safety, Safeguards and 
    Operations Support.
    
    Appendix--Evaluation and Conclusions
    
        On October 18, 1993, a Notice of Violation and Proposed 
    Imposition of Civil Penalty (Notice) was issued for violations 
    identified during an NRC inspection on July 14-16, 1993. Physicians' 
    Laboratory Service, Inc. responded to the Notice on November 17, 
    1993. The Licensee admitted the violations that resulted in the 
    proposed civil penalty, but requested that the NRC reconsider the 
    circumstances surrounding the violations and mitigate the proposed 
    civil penalty. A restatement of the violation, and the NRC's 
    evaluation and conclusions regarding the Licensee's request follow:
    
    Restatement of Violations Assessed a Civil Penalty
    
        10 CFR 35.32 (a) and (e), require, in part, that by January 27, 
    1992, each licensee establish and maintain a written quality 
    management program to provide high confidence that byproduct 
    material or radiation from byproduct material will be administered 
    as directed by the authorized user. The quality management program 
    must include written policies and procedures to meet specific 
    objectives, including that prior to administration, a written 
    directive is prepared for any administration of quantities greater 
    than 30 microcuries of sodium iodide I-125 or I-131.
        10 CFR 35.2, ``Definitions,'' defines a written directive, in 
    part, as an order in writing for a specific patient, dated and 
    signed by an authorized user prior to administration of a 
    radiopharmaceutical and specifies, in part, that for the 
    administration of quantities greater than 30 microcuries of either 
    sodium iodide I-125 or I-131 or any therapeutic administration of a 
    radiopharmaceutical other than sodium iodide I-125 or I-131, the 
    written directive must include the dosage.
        1. Contrary to the above, between January 27, 1992, and July 27, 
    1992, the licensee did not establish a written quality management 
    program (01013).
        2. Contrary to the above, on numerous occasions after January 
    27, 1992, including March 8 and 22, May 13, June 3, and July 1, 
    1993, the licensee administered sodium iodide I-131 for diagnostic 
    purposes in quantities greater than 30 microcuries without a written 
    directive signed by an authorized user (01023).
        These violations represent a Severity Level III problem 
    (Supplement VI).
    
    Civil Penalty--$2,500
    
    Summary of Licensee's Request for Mitigation
    
        In response to the violation involving the failure to establish 
    a written Quality Management Program, the Licensee admitted that it 
    did not establish a Quality Management Program by the January 27, 
    1992 effective date of the rule. The Licensee states that it first 
    learned of the requirement to establish a Quality Management Program 
    following receipt of the June 1992 NMSS Newsletter and that it 
    immediately devised a plan and submitted it to the NRC by July 27, 
    1992. Because corrective action was taken without NRC intervention, 
    the Licensee requested that the violation be dismissed or mitigated 
    to a reprimand without penalty.
        In response to the violation concerning the administration of 
    sodium iodide without a written directive signed by an authorized 
    user, the Licensee admitted that a ``minimal number'' of patients 
    received dosages of greater than 30 microcuries without written 
    directives having been prepared. The Licensee stated that it took 
    immediate corrective action and requested that the violation and the 
    civil penalty be mitigated. In addition, the Licensee requested that 
    the NRC take into account the fact that during the past 23 years, 
    approximately 20,000 to 23,000 diagnostic administrations had 
    occurred with no known misadministrations.
    
    NRC Evaluation of Licensee's Request for Mitigation
    
        The violations were not considered separately in this case. The 
    proposed penalty was based on the aggregate of the two violations 
    (i.e., a Severity Level III problem). Thus, the severity level of 
    the violations was based on their collective significance--that is 
    the combination of not establishing a Quality Management Program 
    until six months after the effective date of the rule and not 
    implementing the requirements of the Quality Management Program even 
    after a written program was established by the Licensee.
        The NRC places a great deal of importance on its Quality 
    Management regulation. Thus, its Enforcement Policy was revised at 
    the same time the rule was adopted to place an emphasis on 
    noncompliance with the rule. Example C.6 was added to Supplement VI, 
    such that violations involving ``A substantial failure to implement 
    the quality management program as required by Sec. 35.32 * * *'' was 
    to be classified at Severity Level III (Note: This was later amended 
    to state ``Substantial failure to implement the quality management 
    program as required by Sec. 35.32 that does not result in a 
    misadministration * * *'').
        The term ``substantial'' has consistently been applied to 
    failures of a programmatic, as opposed to an isolated, nature. In 
    this case, the Licensee's failure was deemed programmatic because 
    the Licensee repeatedly failed to use written directives for 
    diagnostic administrations of sodium iodide I-131 on quantities that 
    exceeded 30 microcuries because of weaknesses in the program. Thus, 
    the violations were appropriately classified in the aggregate as a 
    Severity Level III problem.
        With regard to the magnitude of the proposed civil penalty, the 
    Licensee's argument are related to the civil penalty adjustment 
    factors of Identification, Corrective Action and Licensee 
    Performance. The use of these factors is described in Section VI.B.2 
    of the Enforcement Policy. No adjustment was made to the proposed 
    base penalty with respect to any of these factors.
        Although the Licensee identified its failure to establish a 
    Quality Management Program and corrected it by submitting a plan to 
    the NRC, the plan it submitted lacked specificity, contributing in 
    part to the second violation, the failure to use written directives 
    for diagnostic administrations of I-131 in excess of 30 microcuries. 
    The second violation was identified by the NRC, continued for nearly 
    a year after the Licensee became aware of the regulation, and was 
    occurring at the time of the license transfer. The Licensee's 
    arguments do not provide a basis for mitigation under the 
    identification factor.
        No adjustment was made under the corrective action factor 
    because these violations were discovered after the license had been 
    transferred to another entity. Thus, this factor did not, and still 
    does not, appear to be applicable to the circumstances of this case. 
    In addition, although the Licensee corrected its failure to 
    establish a Quality Management Program, its corrective action was 
    weak, i.e., the Licensee did not implement the use of written 
    directives for diagnostic procedures, as discussed above. Thus, the 
    Licensee has not provided a basis for mitigation under the 
    corrective action factor.
        No adjustment was made under the licensee performance factor. 
    The Licensee's performance was considered relatively poor in the two 
    inspections that preceded the July 14-16, 1993 inspection. Several 
    Severity Level IV and V violations were issued following each of the 
    two prior inspections, one occurring in September 1991 and the other 
    occurring in March 1990. This was balanced, however, against the 
    fact that the July 1993 inspection found only the violations related 
    to the Quality Management rule. Thus, notwithstanding the Licensee's 
    statements about an absence of misadministration, the Licensee has 
    not provided a basis for mitigation under the prior performance 
    factor.
    
    NRC Conclusion
    
        The Licensee has not provided any information that provides a 
    basis for reclassifying the violations or mitigating the proposed 
    civil penalty. The proposed civil penalty in the amount of $2,500 
    should be imposed by order.
    
    [FR Doc. 94-126 Filed 1-4-94; 8:45 am]
    BILLING CODE 7590-01-M
    
    
    

Document Information

Published:
01/05/1994
Department:
Nuclear Regulatory Commission
Entry Type:
Notice
Document Number:
94-126
Pages:
608-610 (3 pages)
Docket Numbers:
Federal Register: January 5, 1994, Docket No. 030-20111, License No. 25-21258-01, EA 93-202